IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2023 Winter Meeting, which is being held in Nashville from March … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Postmenopausal Osteoporosis – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Postmenopausal osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Plasmid DNA Contract Manufacturing Market Size, Share & Trends Analysis Report By Application (Cell & Gene Therapy, Immunotherapy), By Therapeutic Area (Cancer, Infectious Diseases), By End-user, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global plasmid DNA contract manufacturing market size is expected to reach … [Read more…]

Phase 1 study in healthy volunteers lays groundwork for Ent001 evaluation in patients with inflammatory bowel disease and type 1 diabetes MILAN–(BUSINESS WIRE)–Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the start of a Phase 1 first-in-human (FIH) clinical trial with its lead candidate Ent001. Ent001 is a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Biotech Partnering Terms and Agreements 2018-2023” report has been added to ResearchAndMarkets.com’s offering. Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Small Molecule Contract Development and Manufacturing Organization Market 2021-2031 by Product Type, Service Type, Customer Type, Therapeutic Area, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Asia Pacific small molecule contract development and manufacturing organization (CDMO) market will grow by 8.3% annually with a total … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Bronchoscopic Biopsy Device Market Size, Share, & COVID-19 Impact Analysis 2023-2029 – MedCore – Includes: Bronchial Forceps, and Transbronchial Needle Aspiration (TBNA) Needle Devices” report has been added to ResearchAndMarkets.com’s offering. The global market for bronchoscopic biopsy devices was valued at $134.8 million in 2022, with an anticipated increase to $247.1 million … [Read more…]

Sofinnova Partners created and seed financed Noema in 2019 to advance clinical assets in-licensed from Roche This milestone underscores Sofinnova’s ability to form, build and grow companies around people and science that lead to life-changing innovations for patients PARIS–(BUSINESS WIRE)–Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and … [Read more…]

– Completed patient enrollment in its phase 2a trial in Ulcerative Colitis with next- generation live microbiome consortia therapeutic MH002, with topline results expected in Q3 2023. – Has ongoing patient enrollment in its open-label phase 2 trial in the rare disease indication Acute Pouchitis. – Attracted SFPIM, the Belgian Sovereign Wealth Fund, as new … [Read more…]

NEW YORK–(BUSINESS WIRE)–#clinicalresearch—Medidata, a Dassault Systèmes company, today announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering. The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM, and Rave … [Read more…]